C3 glomerulopathy and immune complex membranoproliferative glomerulonephritis
Clinical research in complement-mediated kidney disease centers on C3 glomerulopathy and IC-MPGN, with attention to renal inflammation, proteinuria, and disease recurrence after transplantation.
- C3 glomerulopathy
- immune complex membranoproliferative glomerulonephritis
- proteinuria
- post-transplant recurrence
These studies reflect a strong interest in renal disorders driven by dysregulation of the complement system.
Paroxysmal nocturnal hemoglobinuria
Research in paroxysmal nocturnal hemoglobinuria focuses on a rare hematologic disorder marked by complement-driven hemolysis and related blood abnormalities, with particular attention to adolescent patients.
- paroxysmal nocturnal hemoglobinuria
- hemolysis
- hematologic disease
- adolescent care
The clinical program extends the sponsor’s interest in rare diseases linked to complement inhibition.
Geographic atrophy secondary to age-related macular degeneration
Ophthalmic research addresses geographic atrophy associated with age-related macular degeneration, a progressive retinal condition that affects central vision and retinal integrity.
- geographic atrophy
- age-related macular degeneration
- retinal disease
- vision loss
This area highlights therapeutic interest in ophthalmology and degenerative retinal disease.
Complement pathway modulation
Across its studies, the sponsor focuses on diseases rooted in alternative complement pathway overactivity, linking kidney, blood, and eye disorders through a shared biological mechanism.
- complement pathway
- alternative complement pathway
- rare disease therapeutics
- renal, hematologic, and ophthalmic disorders
Its research portfolio spans multiple clinical areas where complement dysregulation is central to disease activity.
